News

One of the leading pharmaceutical companies in the Middle East and North Africa region, Tabuk Pharmaceuticals enters into licensing and supply agreement with red otc development GmbH on…
Read More...

Alexion Pharmaceuticals, confirmed that Deborah Dunsire, MD has been appointed to its Board of Directors as a new independent director. Dr. Dunsire served as President and Chief…
Read More...

Celgene Corporation and Juno Therapeutics signed a definitive merger agreement in which Celgene has initiated acquisition of Juno Therapeutics. As per the terms of the agreement, …
Read More...

Seattle Genetics confirmed that its collaborator, Takeda Pharmaceutical Company Limited has asserted the fact that European Commission has extended the current conditional marketing…
Read More...

In order to offer a robust, and economically viable solution for anatomical pathology, Enzo Biochem asserted the authentication of a cervical Cancer biomarker detection test offering a…
Read More...

Baxter asserted the approval of U.S. Food and Drug Administration for Bivalirudin in 0.9 percent Sodium Chloride Injection (bivalirudin). Baxter's premixed medications are manufactured…
Read More...

U.S FDA has granted 510 (k) clearance to Bio-Rad Laboratories for the IH-Incubator L and IH-Centrifuge L instruments to be used with the full range of Bio-Rad’s IH-System Gel Reagents…
Read More...

Enzychem Lifesciences Corp asserted that the US Food and Drug Administration has granted Orphan Drug Designation to EC-18 for treating Acute Radiation Syndrome. US FDA Orphan Drug…
Read More...

Astellas Pharma and Vical asserted the negative results for Phase 3 Helios Clinical Trial for ASP0113, an investigational DNA vaccine being developed for cytomegalovirus…
Read More...

Boston-based Biopharmaceutical company, BERG proclaimed that the U.SS FDA has extended orphan-drug designation to the Company's leading product candidate BPM31510, for the treatment of…
Read More...

Immuno-oncology company, Agenus asserted the launch of its proprietary anti- CTLA4 (AGEN1884) and anti-PD1 (AGEN2034) antibodies. The open-label Phase 1/2 study is designed to evaluate…
Read More...

Clinical stage Biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, Pulmatrix sought approval of its Clinical Trial Application from…
Read More...

Amgen affirms optimistic outcomes for Phase 3b LIBERTY study evaluating the efficacy and safety of Aimovig (erenumab) 140 mg in patients with episodic migraine who had experienced two…
Read More...

Medrobotics Corporation asserted that FDA has granted clearance to promulgate the Flex Robotics System for robot-assisted visualization in general surgical, gynecological and thoracic…
Read More...

AstraZeneca and Merck asserted the sanctioning of LYNPARZA tablets for patients with platinum-sensitive relapsed ovarian cancer, regardless of their BRCA mutation status, who responded…
Read More...

Bristol-Myers Squibb Company asserted new data from a cohort of the Phase 2 CheckMate-142 trial assessing Opdivo and Yervoy for the treatment of patients with DNA mismatch repair…
Read More...

SymBio Pharmaceuticals commences a Phase 1 study in Japan for oral TREAKISYM in progressive solid tumors afflicted patients. SymBio sought approval for TREAKISYM injectables…
Read More...

In a bid to offer qualitative bioanalytical and DMPK study services, Concept Life Sciences and Alderly Analytical venture into partnership agreement enumerating having access to…
Read More...

Selexis SA appoints Alberto Garotti as its Chief Financial Officer. Selexis is a life sciences company focusing on revolutionizing mammalian cell line generation technology. Mr. Garotti…
Read More...

Biohaven Pharmaceuticals declared proceeding with its clinical investigation of BHV-5000 as intimated by the US Food and Drug Administration. Enrollment of subjects has begun for the…
Read More...